Frenkel Topping Group Q&A: Continued momentum into 2019 (LON:FEN)
5 September 2019
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the healthcare sector as a pioneering biopharmaceutical company focused on the development of novel treatments for rare and ultra-rare genetic diseases. With..
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has captured the attention of investors with its impressive growth trajectory and a robust pipeline of innovative therapeutic solutions. As a prominent player in the..
Investors eyeing opportunities in the healthcare sector might want to take a closer look at U.S. Physical Therapy, Inc. (NYSE: USPH), a company that stands out with a notable 33.37%..
10x Genomics, Inc. (NASDAQ: TXG) stands as a compelling player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.13 billion, this Pleasanton,..
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stands at an intriguing juncture for investors, especially given its position in the rapidly evolving biotechnology sector. With a market capitalization of $3.19 billion, this..
For investors navigating the ever-evolving landscape of biotechnology stocks, Galapagos NV (NASDAQ: GLPG) presents a unique case study. Headquartered in Mechelen, Belgium, Galapagos operates within the healthcare sector, focusing on..
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biotechnology firm, has emerged as a notable name in the healthcare sector, particularly with its focus on cardiometabolic diseases. With a market..
Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is making waves in the healthcare sector, particularly in the niche market of long-term care facilities (LTCFs) across the United States. As a provider..
SS Innovations International, Inc. (SSII), a trailblazer in the medical devices sector, is making waves in the healthcare industry with its cutting-edge surgical robotics. Headquartered in Gurugram, India, the company..
Dyne Therapeutics, Inc. (NASDAQ: DYN) is currently capturing the attention of investors, with a potential upside of 110.63% according to analyst ratings. This clinical-stage biotechnology company, based in Waltham, Massachusetts,..
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has been capturing investor attention with its strategic focus on innovative therapies within the biotechnology sector. The company, headquartered in Newark, California, is making waves..
ICU Medical, Inc. (NASDAQ: ICUI) stands as a pivotal player in the healthcare sector, specializing in the development and sale of medical instruments and supplies. With a market capitalization of..
BGM Group Ltd. (BGM), a player in the healthcare sector with a focus on the specialty and generic drug manufacturing industry, is navigating challenging market conditions. Based in Chengdu, China,..
LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, has been capturing the attention of investors with its robust..
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is garnering significant attention in the biotechnology sector, particularly due to its impressive 98.06% potential upside as indicated by analyst target price ranges. As a..
Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its promising 56.59% potential upside. As a commercial-stage company headquartered in..
Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 71.66%, according to analyst consensus. Headquartered in Cambridge, Massachusetts, Vericel..
Kestra Medical Technologies, Ltd. (KMTS) has emerged as a noteworthy player within the healthcare sector, specifically in the medical instruments and supplies industry. Based in Kirkland, Washington, the company specializes..
Clover Health Investments, Corp (NASDAQ: CLOV), a player in the healthcare plans sector, is grabbing attention with its significant potential upside of 51.44%. This enticing figure has prompted investors to..
Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention from investors due to its promising pipeline aimed at addressing serious hematologic diseases. With a robust market capitalization..
